Intelligent Bio Solutions partners with IVY Diagnostics to expand EU & Middle East drug screening market

INTELLIGENT BIO SOLUTIONS INC.

Partnership with IVY Diagnostics Srl as key distributor for fingerprint drug screening in Europe and Middle East.
IVY Diagnostics secured a tender for drug rehab programs across Italy using INBS' fingerprint drug screening technology.
INBS' drug screening system undergoing trial with Turin police for roadside screening to test fingerprint-based method.
Expansion to multiple countries: Romania, Hungary, Slovakia, Austria, Scandinavia, UAE, Saudi Arabia, Qatar.
European drug screening market projected at $3.6B by 2030; Middle East & Africa at $432.7M (Grand View Research).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.